Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $6.4760 (-1.14%) ($6.0800 - $6.4800) on Tue. Oct. 29, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.51% (three month average) | RSI | 58 | Latest Price | $6.4760(-1.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -0.9% a day on average for past five trading days. | Weekly Trend | EYES advances 0.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(8%) IGOV(7%) UNG(7%) ICLN(5%) FIVG(4%) | Factors Impacting EYES price | EYES will decline at least -1.755% in a week (0% probabilities). BND(-8%) XLP(-6%) XLK(-6%) QQQ(-6%) LQD(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.755% (StdDev 3.51%) | Hourly BBV | 0 () | Intraday Trend | 2.3% | | | |
|
Resistance Level | $6.59 | 5 Day Moving Average | $6.59(-1.73%) | 10 Day Moving Average | $6.66(-2.76%) | 20 Day Moving Average | $6.59(-1.73%) | To recent high | -15.7% | To recent low | 10.9% | Market Cap | $2.069b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |